Fred E. Cohen
Sits on 5 boards. Overboarded · 5 public boards Last updated September 28, 2026
Time on boards
- Boards served
- 5
- Current seats
- 5
- Board service
- 16 years
- Director since
- 2023
16 years of board service in total across 5 boards, counting each seat separately. Longest: CareDx Inc., 3 years.
CareDx Inc.
Director
Progyny Inc.
Director
Intellia Therapeutics Inc.
Director
UroGen Pharma Ltd.
Director
Kyverna Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 14, 2024 | CareDx Inc. | Grant or award | +10,570 | — | — |
| Jun 12, 2024 | Intellia Therapeutics Inc. | Grant or award | +7,737 | — | — |
| May 23, 2024 | Progyny Inc. | Grant or award | +6,176 | — | — |
| Feb 12, 2024 | Kyverna Therapeutics Inc. | Derivative conversion | +4,523,924 | — | — |
| Jul 26, 2023 | UroGen Pharma Ltd. | Grant or award | +69,339 | $9.54 | $661,494 |
| Jun 16, 2023 | CareDx Inc. | Grant or award | +18,844 | — | — |
| Jun 14, 2023 | Intellia Therapeutics Inc. | Grant or award | +4,425 | — | — |
| May 24, 2023 | Progyny Inc. | Grant or award | +4,385 | — | — |
| Jan 6, 2023 | CareDx Inc. | Grant or award | +1,062 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.